Cryomass Technologies Inc

OTCQX:CRYM USA Drug Manufacturers - Specialty & Generic
Market Cap
$8.13 Million
Market Cap Rank
#42404 Global
#13716 in USA
Share Price
$0.03
Change (1 day)
+4.26%
52-Week Range
$0.03 - $0.04
All Time High
$0.77
About

Cryomass Technologies Inc., together with its subsidiaries, develops and licenses equipment to refine harvested cannabis, hemp, and other premium crops in the United States. It offers CryoSift Separator, which capture intact cannabis and hemp trichomes. The company was formerly known as Andina Gold Corp. and changed its name to Cryomass Technologies Inc. in August 2021. Cryomass Technologies Inc.… Read more

Cryomass Technologies Inc (CRYM) - Total Liabilities

Latest total liabilities as of September 2024: $10.57 Million USD

Based on the latest financial reports, Cryomass Technologies Inc (CRYM) has total liabilities worth $10.57 Million USD as of September 2024.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Cryomass Technologies Inc - Total Liabilities Trend (2017–2023)

This chart illustrates how Cryomass Technologies Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

Cryomass Technologies Inc Competitors by Total Liabilities

The table below lists competitors of Cryomass Technologies Inc ranked by their total liabilities.

Liability Composition Analysis (2017–2023)

This chart breaks down Cryomass Technologies Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.04 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity -1.12 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 9.36 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Cryomass Technologies Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Cryomass Technologies Inc (2017–2023)

The table below shows the annual total liabilities of Cryomass Technologies Inc from 2017 to 2023.

Year Total Liabilities Change
2023-12-31 $6.82 Million +107.44%
2022-12-31 $3.29 Million +59.67%
2021-12-31 $2.06 Million -50.88%
2020-12-31 $4.19 Million +79.52%
2019-12-31 $2.34 Million +3995.44%
2018-12-31 $57.03K -67.81%
2017-12-31 $177.18K --